CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 159 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $347,000 | -23.4% | 770,060 | -14.5% | 0.00% | -33.3% |
| Q2 2018 | $453,000 | -72.4% | 900,185 | +27.7% | 0.00% | -70.0% |
| Q1 2018 | $1,643,000 | +8.0% | 705,038 | +31.6% | 0.01% | +11.1% |
| Q4 2017 | $1,522,000 | -0.9% | 535,938 | -0.2% | 0.01% | 0.0% |
| Q3 2017 | $1,536,000 | +19.9% | 537,113 | +3.5% | 0.01% | +12.5% |
| Q2 2017 | $1,281,000 | +324.2% | 518,738 | +520.6% | 0.01% | +300.0% |
| Q1 2017 | $302,000 | -47.7% | 83,588 | +303.8% | 0.00% | -60.0% |
| Q1 2015 | $577,000 | +26.0% | 20,700 | -17.5% | 0.01% | +25.0% |
| Q4 2014 | $458,000 | -80.0% | 25,100 | -78.7% | 0.00% | -76.5% |
| Q1 2014 | $2,294,000 | – | 117,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |